PROT# A4091016: A Phase 3, Multicenter, Randomized, Long Term Study of the Safety of Tanezumab in Patients with Osteoarthritis of the Knee or Hip

Project: Research project

Project Details

StatusFinished
Effective start/end date7/9/09 → 9/8/12

Funding

  • INC Research, LLC (A4091016 // A4091016)
  • Pfizer Inc. (A4091016 // A4091016)